Skip to main content
OpenTrials
Completed

NCT Number: NCT03337269

Effectiveness of Targeted Educational Interventions at Increasing HPV Vaccine Acceptability and Uptake

This study aims to assess the effectiveness of targeted educational interventions in increasing the acceptability and knowledge of the HPV vaccine among females ages 12 through 26. Subjects will be randomized to one of three study arms (no intervention, viewing an educational video or reading an educational handout) and then a questionnaire will be administered to assess knowledge and acceptability of the HPV vaccine. Subject charts will be reviewed to assess for initiation of the HPV vaccine.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

HPV-Related Cervical Carcinoma

Age range

12 year–26 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

University of Pennsylvania

Philadelphia, Pennsylvania, 19104, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Females ages greater than or equal to 12 years and less than or equal to 26 years
  • Presenting to a gynecology clinic for a routine or problem visit
  • Ability to read and write

Exclusion criteria

  • Women ages less than or greater than 12 years or greater than 26 years
  • Women with known cervical cancer
  • Known pregnancy
  • Prior initiation or completion of the HPV vaccine series

Treatment and study plan

Educational Video

Other

Approximately 7 minute video on the HPV vaccine

Educational handout

Other

One page handout on the HPV vaccine

Control

Other

Control

Primary outcomes

  1. HPV vaccine acceptability

    Time frame: Up to 6 months

    Subject reported willingness to accept the HPV vaccination, as assessed through agreement or disagreement to the statement "I would be willing to accept the HPV vaccine today."

Secondary outcomes

  1. HPV vaccine knowledge

    Time frame: Up to 6 months

    Subject knowledge of the HPV vaccine and its associated risks and benefits, as assessed through a survey. Subjects are asked to answer 7 questions and total knowledge score is calculated by an unweighted sum of correct answers.

Sponsors and collaborators

Lead sponsor

University of Pennsylvania

Other

Registry information

Important dates

Study start
2017
Primary completion
2017
Study completion
2018
First posted
Nov 8, 2017
Registry last updated
Apr 11, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.